FDA Drug Application (009698) for MILTOWN by MEDPOINTE PHARM HLC

Back to FDA Applications sponsored by MEDPOINTE PHARM HLC

Application Number009698
Product Number002
FormTABLET;ORAL
Dosage400MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameMILTOWN
Active IngredientMEPROBAMATE



Back to FDA Applications sponsored by MEDPOINTE PHARM HLC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.